Role of programmed death ligands in effective T-cell interactions in extranodal natural killer/T-cell lymphoma
Lijuan Han(Centre National de la Recherche Scientifique), Mingzhi Zhang(Chinese Academy of Sciences), Fei‐Fei Liu(Jiangsu Hengrui Medicine (China)), Zhaoming Li(First Affiliated Hospital of Zhengzhou University), Ken H. Young(Duke Medical Center), Xudong Zhang(Agricultural Genomics Institute at Shenzhen), Ruping Li(Zhengzhou University), Tengpeng Hu(First Affiliated Hospital of Zhengzhou University), Yi Zhang(Tianjin Medical University General Hospital), Jianguo Wen(Argonne National Laboratory), Suke Sun(First Affiliated Hospital of Zhengzhou University), Xinfeng Chen(Henan Cancer Hospital), Zhi‐Yuan Zhou(Tsinghua University)
Cited by 53
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
|Cellular Physiology and Biochemistry|2017|4.1k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Roles of IFN-γ in tumor progression and regression: a review
|Biomarker Research|2020|1.2k